Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.
Novel tuberculosis vaccines are in varying stages of pre-clinical and clinical development. This study seeks to estimate the potential cost-effectiveness of a BCG booster vaccine, while accounting for costs of large-scale clinical trials, using the MVA85A vaccine as a case study for estimating poten...
Guardado en:
Autores principales: | Jared B Ditkowsky, Kevin Schwartzman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9f4299067c942ee8201e9b652c97629 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
por: Nicola Foster, et al.
Publicado: (2021) -
The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
por: Lesong Conteh, et al.
Publicado: (2010) -
The Implication of Xenophobic Violence on Nigeria-South Africa Relations
por: Ismail Bello, et al.
Publicado: (2017) -
A Spatial Analysis of Tuberculosis Related Mortality in South Africa
por: Dan Kibuuka, et al.
Publicado: (2021) -
Fake news and fallacies: Exploring vaccine hesitancy in South Africa
por: Avania Bangalee, et al.
Publicado: (2021)